Logo image of CUR.CA

CONSOLIDATED URANIUM INC (CUR.CA) Stock Fundamental Analysis

TSX-V:CUR - CA21024C1014 - Common Stock

1.93 CAD
+0.05 (+2.66%)
Last: 12/8/2023, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CUR. CUR was compared to 803 industry peers in the Metals & Mining industry. CUR may be in some trouble as it scores bad on both profitability and health. CUR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

CUR had negative earnings in the past year.
CUR had a negative operating cash flow in the past year.
CUR had negative earnings in each of the past 5 years.
CUR had a negative operating cash flow in each of the past 5 years.
CUR.CA Yearly Net Income VS EBIT VS OCF VS FCFCUR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -410.01%, CUR is not doing good in the industry: 93.10% of the companies in the same industry are doing better.
With a Return On Equity value of -563.23%, CUR is not doing good in the industry: 83.83% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -410.01%
ROE -563.23%
ROIC N/A
ROA(3y)-106.62%
ROA(5y)-158.47%
ROE(3y)-131.22%
ROE(5y)-182.34%
ROIC(3y)N/A
ROIC(5y)N/A
CUR.CA Yearly ROA, ROE, ROICCUR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300 -400

1.3 Margins

CUR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CUR.CA Yearly Profit, Operating, Gross MarginsCUR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022

3

2. Health

2.1 Basic Checks

The number of shares outstanding for CUR has been increased compared to 1 year ago.
Compared to 1 year ago, CUR has an improved debt to assets ratio.
CUR.CA Yearly Shares OutstandingCUR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
CUR.CA Yearly Total Debt VS Total AssetsCUR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

CUR has an Altman-Z score of -2.57. This is a bad value and indicates that CUR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CUR (-2.57) is worse than 69.08% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that CUR is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.03, CUR is not doing good in the industry: 63.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.57
ROIC/WACCN/A
WACCN/A
CUR.CA Yearly LT Debt VS Equity VS FCFCUR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

2.3 Liquidity

CUR has a Current Ratio of 3.60. This indicates that CUR is financially healthy and has no problem in meeting its short term obligations.
CUR has a Current ratio (3.60) which is comparable to the rest of the industry.
CUR has a Quick Ratio of 3.60. This indicates that CUR is financially healthy and has no problem in meeting its short term obligations.
CUR's Quick ratio of 3.60 is in line compared to the rest of the industry. CUR outperforms 59.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
CUR.CA Yearly Current Assets VS Current LiabilitesCUR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.86% over the past year.
EPS 1Y (TTM)36.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

CUR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.49% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-147.2%
EPS Next 2Y-1.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CUR.CA Yearly EPS VS EstimatesCUR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 -0.1 -0.2 -0.3 -0.4

0

4. Valuation

4.1 Price/Earnings Ratio

CUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CUR.CA Price Earnings VS Forward Price EarningsCUR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CUR.CA Per share dataCUR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.49%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CONSOLIDATED URANIUM INC

TSX-V:CUR (12/8/2023, 7:00:00 PM)

1.93

+0.05 (+2.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap199.71M
Analysts84
Price Target5.1 (164.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25%
PT rev (3m)25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.12
P/tB 14.12
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -410.01%
ROE -563.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-106.62%
ROA(5y)-158.47%
ROE(3y)-131.22%
ROE(5y)-182.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 230.53%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z -2.57
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.32%
EPS Next Y-147.2%
EPS Next 2Y-1.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.75%
OCF growth 3YN/A
OCF growth 5YN/A